274 related articles for article (PubMed ID: 19758114)
1. The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases.
Gasparyan AY; Stavropoulos-Kalinoglou A; Mikhailidis DP; Toms TE; Douglas KM; Kitas GD
Curr Vasc Pharmacol; 2010 Jul; 8(4):437-49. PubMed ID: 19758114
[TBL] [Abstract][Full Text] [Related]
2. Accelerated atherogenesis in autoimmune rheumatic diseases.
Bacon PA; Stevens RJ; Carruthers DM; Young SP; Kitas GD
Autoimmun Rev; 2002 Dec; 1(6):338-47. PubMed ID: 12848989
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease in autoimmune rheumatic diseases.
Hollan I; Meroni PL; Ahearn JM; Cohen Tervaert JW; Curran S; Goodyear CS; Hestad KA; Kahaleh B; Riggio M; Shields K; Wasko MC
Autoimmun Rev; 2013 Aug; 12(10):1004-15. PubMed ID: 23541482
[TBL] [Abstract][Full Text] [Related]
4. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.
Soltész P; Kerekes G; Dér H; Szücs G; Szántó S; Kiss E; Bodolay E; Zeher M; Timár O; Szodoray P; Szegedi G; Szekanecz Z
Autoimmun Rev; 2011 May; 10(7):416-25. PubMed ID: 21281743
[TBL] [Abstract][Full Text] [Related]
5. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia.
Hahn BH; Grossman J; Chen W; McMahon M
J Autoimmun; 2007; 28(2-3):69-75. PubMed ID: 17433865
[TBL] [Abstract][Full Text] [Related]
6. Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.
Zinger H; Sherer Y; Shoenfeld Y
Clin Rev Allergy Immunol; 2009 Aug; 37(1):20-8. PubMed ID: 18991025
[TBL] [Abstract][Full Text] [Related]
7. Accelerated Atherosclerosis and Management of Cardiovascular Risk in Autoimmune Rheumatic Diseases: An Updated Review.
Karakasis P; Patoulias D; Stachteas P; Lefkou E; Dimitroulas T; Fragakis N
Curr Probl Cardiol; 2023 Dec; 48(12):101999. PubMed ID: 37506959
[TBL] [Abstract][Full Text] [Related]
8. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
Bruce IN
Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory lipids as a target for therapy in the rheumatic diseases.
McMahon M; Brahn E
Expert Opin Investig Drugs; 2008 Aug; 17(8):1213-24. PubMed ID: 18616417
[TBL] [Abstract][Full Text] [Related]
10. Arterial distensibility in chronic inflammatory rheumatic disorders.
Yildiz M
Open Cardiovasc Med J; 2010 Feb; 4():83-8. PubMed ID: 20461114
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction in rheumatic autoimmune diseases.
Murdaca G; Colombo BM; Cagnati P; Gulli R; Spanò F; Puppo F
Atherosclerosis; 2012 Oct; 224(2):309-17. PubMed ID: 22673743
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular co-morbidity in rheumatic diseases.
Turesson C; Jacobsson LT; Matteson EL
Vasc Health Risk Manag; 2008; 4(3):605-14. PubMed ID: 18827910
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases.
Lisitsyna TA; Veltishchev DY; Seravina OF; Kovalevskaya OB; Starovoytova MN; Desinova OV; Abramkin AA; Ovcharov PS; Vasil'ev VI; Alekberova ZS; Krasnov VN; Nasonov EL
Ter Arkh; 2018 May; 90(5):30-37. PubMed ID: 30701894
[TBL] [Abstract][Full Text] [Related]
14. Disease modification and cardiovascular risk reduction: two sides of the same coin?
Hall FC; Dalbeth N
Rheumatology (Oxford); 2005 Dec; 44(12):1473-82. PubMed ID: 16076883
[TBL] [Abstract][Full Text] [Related]
15. Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis.
Tektonidou MG; Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Protogerou A
Autoimmun Rev; 2017 Mar; 16(3):308-312. PubMed ID: 28147263
[TBL] [Abstract][Full Text] [Related]
16. Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity.
Kravvariti E; Konstantonis G; Sfikakis PP; Tektonidou MG
Rheumatology (Oxford); 2018 Dec; 57(12):2158-2166. PubMed ID: 30102390
[TBL] [Abstract][Full Text] [Related]
17. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis.
Abou-Raya A; Abou-Raya S
Autoimmun Rev; 2006 May; 5(5):331-7. PubMed ID: 16782558
[TBL] [Abstract][Full Text] [Related]
18. The relationship between inflammatory and oxidative stress biomarkers, atherosclerosis and rheumatic diseases.
Şerban C; Drăgan S
Curr Pharm Des; 2014; 20(4):585-600. PubMed ID: 23565633
[TBL] [Abstract][Full Text] [Related]
19. Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases.
Arida A; Protogerou AD; Kitas GD; Sfikakis PP
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954107
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.
Mason JC; Libby P
Eur Heart J; 2015 Feb; 36(8):482-9c. PubMed ID: 25433021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
